[go: up one dir, main page]

AU2003248150A1 - Exosome containing exogenous antigen through gene transfection and method for utilizing the same - Google Patents

Exosome containing exogenous antigen through gene transfection and method for utilizing the same

Info

Publication number
AU2003248150A1
AU2003248150A1 AU2003248150A AU2003248150A AU2003248150A1 AU 2003248150 A1 AU2003248150 A1 AU 2003248150A1 AU 2003248150 A AU2003248150 A AU 2003248150A AU 2003248150 A AU2003248150 A AU 2003248150A AU 2003248150 A1 AU2003248150 A1 AU 2003248150A1
Authority
AU
Australia
Prior art keywords
utilizing
same
exogenous antigen
gene transfection
containing exogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003248150A
Inventor
Jung Ah Cho
Chul Woo Kim
Jae Kyun Ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOUVAX CO Ltd
Original Assignee
NOUVAX CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOUVAX CO Ltd filed Critical NOUVAX CO Ltd
Publication of AU2003248150A1 publication Critical patent/AU2003248150A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003248150A 2002-08-13 2003-08-06 Exosome containing exogenous antigen through gene transfection and method for utilizing the same Abandoned AU2003248150A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2002-0047779 2002-08-13
KR10-2002-0047779A KR100519384B1 (en) 2002-08-13 2002-08-13 Manufacturing method of exosomes using gene transfection and use of the same
PCT/KR2003/001575 WO2004014954A1 (en) 2002-08-13 2003-08-06 Exosome containing exogenous antigen through gene transfection and method for utilizing the same

Publications (1)

Publication Number Publication Date
AU2003248150A1 true AU2003248150A1 (en) 2004-02-25

Family

ID=31713115

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003248150A Abandoned AU2003248150A1 (en) 2002-08-13 2003-08-06 Exosome containing exogenous antigen through gene transfection and method for utilizing the same

Country Status (3)

Country Link
KR (1) KR100519384B1 (en)
AU (1) AU2003248150A1 (en)
WO (1) WO2004014954A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322115C (en) * 2005-07-06 2007-06-20 清华大学 Ectobody loaded with exogenous ligand molecule and its preparation method and application
GB2437727B (en) * 2006-05-04 2011-04-20 Univ Open Aptamers directed to MUC1
EP3569254B1 (en) 2009-04-17 2022-07-20 Oxford University Innovation Limited Composition for delivery of genetic material
ES2362589B1 (en) 2009-12-28 2012-05-16 Centre De Recerca En Salut Internacional De Barcelona EXOSOMES DERIVED FROM RETICULOCITS INFECTED WITH PLASMODIUM SP., METHOD FOR OBTAINING AND USE.
GB201121070D0 (en) 2011-12-07 2012-01-18 Isis Innovation composition for delivery of biotherapeutics
PL2972193T3 (en) 2013-03-13 2020-08-24 University Of Miami Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
PT3527670T (en) 2013-03-15 2024-01-18 Beth Israel Deaconess Medical Ct Inc Mirna biogenesis in exosomes for diagnosis and therapy
AU2014360344B2 (en) 2013-12-04 2018-11-29 Board Of Regents, The University Of Texas System Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis
EA201890006A1 (en) 2015-06-10 2018-05-31 Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем APPLICATION OF THE EXOSOM FOR THE TREATMENT OF THE DISEASE
JP2017101012A (en) * 2015-11-30 2017-06-08 義之 小山 Immunotherapy preparation
CN108473973A (en) 2016-09-30 2018-08-31 赛尔莱克斯生命科学公司 Including the composition of the excretion body of load albumen and preparation and the method for delivering the composition
JP2021536257A (en) * 2018-09-06 2021-12-27 イェディテペ・ウニヴェルシテシYeditepe Universitesi Use of plant exosomes to show regulatory effects on immune system cells
US20220072049A1 (en) 2020-08-21 2022-03-10 University Of Miami Compositions and methods of treatment using microvesicles from bone marrow-derived mesenchymal stem cells
EP4316467A4 (en) 2021-03-30 2025-04-09 Kainos Medicine, Inc. FAS-ASSOCIATED FACTOR 1 (FAF1)-LOADED EXOSOMES AND THEIR USE AS AN ANTICANCER AGENT
US20230390341A1 (en) 2022-04-19 2023-12-07 University Of Miami Methods and compositions for prevention and treatment of graft versus host disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198642A1 (en) * 1995-08-03 2003-10-23 Johannes J. Geuze Cell derived antigen presenting vesicles
FR2766205B1 (en) * 1997-07-16 2002-08-30 Inst Nat Sante Rech Med NOVEL METHOD FOR SENSITIZING ANTIGEN PRESENTING CELLS AND NOVEL MEANS FOR IMPLEMENTING THE METHOD
FR2785543B1 (en) * 1998-11-05 2003-02-28 Inst Nat Sante Rech Med MODIFIED EXOSOMES AND USES
US20040241176A1 (en) * 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles

Also Published As

Publication number Publication date
KR100519384B1 (en) 2005-10-06
WO2004014954A1 (en) 2004-02-19
KR20040015508A (en) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2002311043A1 (en) System and method for customized time display
AU2003210243A1 (en) Method for systemic drug delivery through the nail
AU2003206095A1 (en) Methods and means for amplifying nucleic acid
AU2003285228A1 (en) Peripheral support apparatus and method
AU2003248150A1 (en) Exosome containing exogenous antigen through gene transfection and method for utilizing the same
AU2003210497A1 (en) Gene delivery system and methods of use
AU2003299864A1 (en) Sirna compounds and methods for the downregulation of gene expression
AU2002238874A1 (en) Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors
AU2003225756A1 (en) Silica-based materials and methods
AU2003266656A1 (en) Cushion and method of evaluating the cushion
AU3425700A (en) Non-ribosomal peptide synthetases, method for producing same and the use thereof
AU2003277844A1 (en) Dispensing system and method
AU2002365188A1 (en) Nucleic acid delivery and expression
AU2003247511A1 (en) Dispensing apparatus and method
AU2002254031A1 (en) Non aggregating fluorescent proteins and methods for using the same
AU2001297738A1 (en) Gene delivery device and gene delivery method
AU2003268638A1 (en) Sharging method and charging system
AU2003297177A1 (en) Spliced yarn and method for forming the same
AU2003281386A1 (en) Advertising method and means
AU2001252591A1 (en) Novel promoters and gene expression method by using the promoters
AU2003265366A1 (en) Recharging method and apparatus
AU2003239589A1 (en) Eta-1 gene and methods for use
AU2002952858A0 (en) Dna isolation material and method
AU2003298934A1 (en) Method and apparatus for determining gene expression levels
AU2003282413A1 (en) Advertising system for subway and method of controlling the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase